| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.0M | — | +2177.9% |
| R&D Expense | $34.6M | -0.1% | +86.0% |
| SG&A Expense | $10.6M | +1.6% | -39.9% |
| Operating Income | -$35.3M | +21.9% | +1.6% |
| Net Income | -$24.3M | +28.2% | +13.4% |
| EPS (Basic) | -$0.39 | +29.1% | +23.5% |
| EPS (Diluted) | -$0.39 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $48.4M | -7.7% | +80.9% |
| Short-term Investments | $940.6M | -0.3% | +49.0% |
| Current Assets | $998.1M | -0.7% | +49.8% |
| Total Assets | $1.02B | -0.7% | +47.4% |
| Current Liabilities | $27.8M | +30.2% | +62.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$53.7M | — | — |
| Capital Expenditures | $937K | — | — |
| Investing Cash Flow | -$330.5M | — | — |
| Financing Cash Flow | $2.0M | — | — |
| Free Cash Flow | -$54.6M | — | — |
| +29.1% |
| +23.5% |
| $48.2M |
| +15.6% |
| +23.9% |
| Stockholders' Equity | $976.6M | -1.4% | +48.8% |